This move is archived. Current quotes and coverage live on the stock page.
Follow AVCR
Avricore Health Inc experienced a significant jump in its stock price, reflecting positive investor sentiment and strategic developments.
Avricore Health Inc (AVCR.V) saw its stock price rise by 15.38% in yesterday's trading session, closing at CA$0.07. This surge can be attributed to recent company announcements and developments that have captured investor interest.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
-15.38%
Beta
0.36
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
205.9%
Annualized
90-Day Vol
155.1%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.03 – C$0.11 |
| 60 trading days | C$0.06 | C$0.02 – C$0.15 |
| 90 trading days | C$0.06 | C$0.02 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may view Avricore's strategic partnerships and innovative healthcare solutions as key drivers for future growth, making it a stock to watch in the healthcare sector.
Stock Price Jumped 15.38%
Avricore Health's market cap now stands at approximately CA$9.48 million, reflecting growing investor confidence.
Bull case
The recent collaboration with Abbott to distribute point-of-care testing products through HealthTab™ positions Avricore Health as a leader in pharmacy-based health solutions. This partnership could lead to significant revenue growth as more pharmacies adopt these innovative testing options.
Bear case
Despite the positive momentum, investors should remain cautious. Avricore is not yet profitable, and there are inherent risks associated with early-stage healthcare technologies that could impact its future performance.
Recent Developments
Advertisement
Avricore Health's stock surge can be linked to its recent announcement about granting stock options to directors and employees, signaling management's confidence in the company's future. Additionally, their partnership with Abbott enhances their HealthTab™ platform, expanding their reach in the UK market.
Market Reaction
The market's positive reaction to Avricore's announcements reflects a growing interest in healthcare stocks, especially those innovating in point-of-care testing. Investors seem optimistic about the company's growth potential, even though it currently lacks profitability.
Looking Ahead
As Avricore Health continues to expand its services and partnerships, investors will be keenly watching for further developments. The company's focus on integrating technology in pharmacy practices could position it well for future success, but it must navigate the challenges of the competitive healthcare landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
